We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.29B
AUM Growth
+$712M
Cap. Flow
-$287M
Cap. Flow %
-3.94%
Top 10 Hldgs %
31.93%
Holding
280
New
22
Increased
61
Reduced
163
Closed
30

Top Buys

Rank Stock Value
1
LPLA icon
LPL Financial
LPLA
+$52.3M
2
ASAN icon
Asana
ASAN
+$25.8M
3
KNF icon
Knife River
KNF
+$21.2M
4
COUR icon
Coursera
COUR
+$21M
5
MNDY icon
monday.com
MNDY
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 34.33%
2 Consumer Discretionary 19.26%
3 Healthcare 14.28%
4 Communication Services 12.26%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLX icon
251
Amylyx Pharmaceuticals
AMLX
$3.71B
-688,438
Closed -$12.6M
AVGO icon
252
Broadcom
AVGO
$1.65T
-7,560
Closed -$628K
BEAM icon
253
Beam Therapeutics
BEAM
$2.43B
-105,515
Closed -$2.54M
BRCC icon
254
BRC Inc
BRCC
$127M
-57,017
Closed -$2.05M
CAVA icon
255
CAVA Group
CAVA
$6.24B
-6,875
Closed -$211K
CLFD icon
256
Clearfield
CLFD
$395M
-17,515
Closed -$502K
VISN
257
Vistance Networks Inc
VISN
$1.52B
-100,761
Closed -$339K
DGII icon
258
Digi International
DGII
$2.55B
-168,064
Closed -$4.54M
DOCU
259
DocuSign
DOCU
$13.1B
-36,975
Closed -$1.55M
ETNB
260
DELISTED
89bio
ETNB
-81,207
Closed -$1.25M
FLYW icon
261
Flywire
FLYW
$2.19B
-131,777
Closed -$4.2M
GDRX icon
262
GoodRx Holdings
GDRX
$1.2B
-108,061
Closed -$608K
KYMR icon
263
Kymera Therapeutics
KYMR
$9.44B
-81,865
Closed -$1.14M
MLTX icon
264
MoonLake Immunotherapeutics
MLTX
$1.05B
-14,959
Closed -$853K
ORCL icon
265
Oracle
ORCL
$414B
-61,681
Closed -$6.53M
PEN icon
266
Penumbra
PEN
$12.6B
-4,099
Closed -$992K
PRTS icon
267
CarParts.com
PRTS
$69M
-10,033
Closed -$413K
RDFN
268
DELISTED
Redfin
RDFN
-19,131
Closed -$135K
SIBN icon
269
SI-BONE Inc
SIBN
$831M
-40,984
Closed -$871K
STKS icon
270
The ONE Group
STKS
$50.4M
-220,127
Closed -$1.21M
TCMD icon
271
Tactile Systems Technology
TCMD
$509M
-346,963
Closed -$4.87M
TMO icon
272
Thermo Fisher Scientific
TMO
$232B
-9,929
Closed -$5.03M
VITL icon
273
Vital Farms
VITL
$421M
-32,305
Closed -$374K
WFC icon
274
Wells Fargo
WFC
$276B
-52,226
Closed -$2.13M
BWIN
275
Baldwin Insurance Group
BWIN
$3.11B
-46,400
Closed -$1.08M

Similar funds

Gilder Gagnon Howe & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Gilder Gagnon Howe & Co held 280 positions worth $7.29B, up 11% from $6.57B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $287M in Q4 2023, closing 30 positions and reducing 163 holdings. Its most notable exit was Amylyx Pharmaceuticals, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Asana worth $25.2M.

  • Gilder Gagnon Howe & Co's largest Q4 2023 buy was Asana: 1,328,019 shares worth $25.2M.
  • Gilder Gagnon Howe & Co added most to LPL Financial in Q4 2023, an estimated $52.3M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2023 reduction was Canadian Pacific Kansas City, cutting an estimated $82M.
  • Gilder Gagnon Howe & Co fully exited Amylyx Pharmaceuticals in Q4 2023, selling an estimated $12.6M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $7.29B portfolio in Q4 2023.
  • Gilder Gagnon Howe & Co opened 22 new positions and closed 30 in Q4 2023.
  • Gilder Gagnon Howe & Co's portfolio value rose 11% quarter-over-quarter to $7.29B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2023, filed 14 Feb 2024.